Lopital and Holland Capital join forces to achieve growth

Amsterdam, 21 August 2023Holland Capital invests in Lopital, one of the market leaders in the Netherlands in the field of innovative hygiene and mobility tools, active in more than 25 countries. Holland Capital supports the organization in its growth plans by focusing on both organic growth and buy-and-build opportunities, both nationally and internationally.

Hygiene and mobility aids for healthcare

The increasing aging population and the resulting pressure on healthcare highlights the need for more attention to healthcare staff. Physical strain and excessive workload are the main causes of high absenteeism among healthcare providers. Lopital develops, assembles, and implements high-quality aids to prevent physical strain and reduce workload.

Lopital distinguishes itself through its unique adaptability and customer-centric approach. Its products are specially designed to provide optimal hygienic care by healthcare providers to their clients, meeting specific customer needs. This makes Lopital’s products versatile and suitable for various caregivers and clients. Another advantage of Lopital’s product line is the use of a uniform technology, allowing healthcare providers to quickly become familiar with the tools’ functionality and efficiency.

In addition to high-quality healthcare aids, Lopital offers tailored training for healthcare professionals to maximize the products’ benefits and improve patient care. Lopital has developed a unique digital service and maintenance portal, which monitors and proactively addresses the aids’ service needs. This ensures functional tools for healthcare providers and clients, with quick solutions for maintenance needs and efficient delivery of replacement parts.

Investment for growth

Holland Capital supports the organization in its growth plans by focusing on both organic growth and buy-and-build opportunities, both nationally and internationally.

Jan van Megen (CEO Lopital) states, “I am delighted and proud to work alongside the Lopital team and Holland Capital in guiding our organization to the next phase of growth and development. Due to aging populations and the shortage of healthcare workers in the job market, the global market is experiencing significant growth. Lopital’s products have a profound impact on the well-being and health of both clients and healthcare staff. We have a strong company with an excellent foundation from which we will achieve our growth ambitions. Key pillars include international expansion, portfolio development, incorporating complementary companies, and the creation of new business models and value propositions.”

Cees van Dam, Roland van Amelsfoort, René Dröge declare, “After 39 years, it was time to pass the torch, and we are pleased to secure the future of Lopital and its employees by bringing in the new CEO Jan van Megen and experienced investor Holland Capital. It has been an unforgettable journey, with incredible changes in the healthcare landscape, and we are proud to have played a significant role. We look back with pride on a fantastic time and sincerely thank our employees, customers, and suppliers for their loyalty and collaboration.”

Hubert Verbeek, Managing Partner of Holland Capital, expresses, “We are proud to add Lopital, with over 45 years of experience as a manufacturer and distributor of healthcare mobility equipment, to our portfolio of healthcare companies. In the midst of current challenges within healthcare, Lopital takes on an important role, striving for solutions that prioritize staff shortages, high workload, and patient focus. We look forward to realizing growth ambitions together with the team.”

About Lopital

Founded in 1977, Lopital operates from its office in Oisterwijk, with a team of 47 employees active in over 25 countries. Lopital offers a wide range of sustainable, (MDR) certified, and high-quality products to healthcare institutions, hospitals, home care dealers, and international distributors.

About Holland Capital

Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 160 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare, Technology and Food & Agri. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.

Private Equity Internship | Junior Investment Analyst

Private Equity Internship | Junior Investment Analyst

Do you want to step into the exciting world of Private Equity? Holland Capital, an independent private equity firm with a focus on the Benelux & German mid-market, is looking for a full-time intern to join its buy-out team.Within 5 months, you will familiarize...

Portfolio company Inno4Life sold to the Swiss company Dec Group

Portfolio company Inno4Life sold to the Swiss company Dec Group Amsterdam, April 16, 2020 - Earlier this month, Inno4Life, a manufacturer of machines for the pharmaceutical industry, was sold to the Swiss Dec Group. Inno4Life's management will remain actively involved...

Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411


Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120